HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
Michael B. Maris(Colorado Blood Cancer Institute), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ed Agura, Monic J. Stuart(United States Department of Veterans Affairs), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Effie W. Petersdorf(University of Washington), Claudio Anasetti(Moffitt Cancer Center), Michael A. Pulsipher(Primary Children's Hospital), Ute Hegenbart(Heidelberg University), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Karl G. Blume(City Of Hope National Medical Center), John T. Slattery(United States Department of Veterans Affairs), Shelly Heimfeld(Fred Hutch Cancer Center), Barry E. Storer(City Of Hope National Medical Center), David G. Maloney(Fred Hutch Cancer Center)
Cited by 337
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k